We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
KBC Group
51
KBC Group
Belgium
$8K +$4.42K +950 +100%
Citigroup
52
Citigroup
New York
$5K +$5.29K +1,135 New
Wells Fargo
53
Wells Fargo
California
$4K -$5.59K -1,200 -60%
PCM
54
Prelude Capital Management
New York
$4K -$456 -98 -11%
Barclays
55
Barclays
United Kingdom
$4K +$2.79K +600 +221%
QT
56
Quantamental Technologies
New York
$3K +$466 +100 +17%
RE
57
RBC Europe
United Kingdom
$2.58K
LTFS
58
Ladenburg Thalmann Financial Services
Florida
$2K -$2.02K -435 -47%
AG
59
Advisor Group
Arizona
$2K
NFG
60
Next Financial Group
Texas
$2K
NFH
61
NEXT Financial Holdings
Texas
$2K +$2.21K +475 New
Bank of America
62
Bank of America
North Carolina
$1K -$4.2K -901 -77%
Daiwa Securities Group
63
Daiwa Securities Group
Japan
$1K
PA
64
Parallel Advisors
California
$1K
GT
65
Glenmede Trust
Pennsylvania
$1K +$1.75K +375 New
ED
66
Exane Derivatives
France
$520
FCMI
67
Foresite Capital Management II
California
-$4.03M -700,000 Closed
Balyasny Asset Management
68
Balyasny Asset Management
Illinois
-$3.26M -567,401 Closed
A
69
Abingworth
United Kingdom
-$1.44M -250,000 Closed
BG
70
Bellevue Group
Switzerland
-$754K -131,135 Closed
Marshall Wace
71
Marshall Wace
United Kingdom
-$748K -130,050 Closed
Ameriprise
72
Ameriprise
Minnesota
-$686K -119,280 Closed
Squarepoint
73
Squarepoint
New York
-$622K -108,100 Closed
OIM
74
Oracle Investment Management
Connecticut
-$304K -52,921 Closed
CM
75
Caption Management
Oklahoma
-$293K -50,960 Closed